Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.95 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HRH1 | P35367 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.52 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.50 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.50 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.46 |
| ▸ | CHAT | P28329 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL589251 | 0.98 | — | — | |
| SCHEMBL29961324 | 0.98 | — | — | |
| Bromide SCHEMBL29392397 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| Fluoride Ion SCHEMBL7937290 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL461720 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| Water SCHEMBL9445012 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL29438523 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| Bromide SCHEMBL367171 | 0.95 | HDAC8 (0.95) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL5162131 | 0.90 | HDAC8 (0.84) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT | |
| SCHEMBL19971548 | 0.90 | HDAC8 (0.84) | HDAC8KDM4ESMN1; SMN2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019180126-A1 | PVA-BASED C3MS TO INHIBIT ICE RECRYSTALLIZATION AND MANUFACTURE POLYMER COATINGS THAT REDUCE ICE ADHESION | TECHNISCHE UNIVERSITEIT EINDHOVEN (NL) | 2019-09-26 | — | — | WO | claimed |
| CN-104629756-A | Method of making nanoparticle composites | NANJING UNIVERSITY OF TECHNOLOGY | 2015-05-20 | — | — | CN | claimed |
| US-20150129793-A1 | METHODS OF MAKING NANOPARTICLE COMPOSITES | NANJING UNIVERSITY OF TECHNOLOGY (CN) | 2015-05-14 | — | — | US | claimed |
| US-8409621-B2 | Forming controlled release, core shell drug delivery materials; charge voltage accelerating second liquid stream to surround first stream and vibrating | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2013-04-02 | — | — | US | claimed |
| US-8318191-B2 | Porous material having hierarchical porous structure and preparation method thereof | KOREAN INSTITUTE OF MACHINERY & MATERIALS (KR) | 2012-11-27 | — | — | US | claimed |
| WO-2011011050-A2 | CHEMICAL HYDRIDE FORMULATION AND SYSTEM DESIGN FOR CONTROLLED GENERATION OF HYDROGEN | ARDICA TECHNOLOGIES, INC. (US) | 2011-01-27 | — | — | WO | claimed |
| US-20110020215-A1 | Chemical hydride formulation and system design for controlled generation of hydrogen | INTELLIGENT ENERGY LIMITED (GB) | 2011-01-27 | — | — | US | claimed |
| US-20100266836-A1 | MESOSTRUCTURED SKINS FOR APPLICATION IN THE AERONAUTICS AND AEROSPACE INDUSTRIES | EURO. AERONAUTIC DEFENCE AND SPACE CO. EADS FRANCE (FR) | 2010-10-21 | — | — | US | claimed |
| US-20100010513-A1 | POROUS MATERIAL HAVING HIERARCHICAL POROUS STRUCTURE AND PREPARATION METHOD THEREOF | KOREAN INSTITUTE OF MACHINERY & MATERIALS (KR) | 2010-01-14 | — | — | US | claimed |
| WO-2009076754-A1 | SINGLE LAYERED CONTROLLED RELEASE THERAPEUTIC SYSTEM | PHARMASCIENCE INC. (CA) | 2009-06-25 | — | — | WO | claimed |
| WO-2008152490-A2 | LOADED TARGET-SPECIFIC VESICLES, METHOD OF PRODUCING THE VESICLES AND THEIR USE IN MEDICAL IMAGING | UNIVERSITÄT BASEL (CH) | 2008-12-18 | — | — | WO | claimed |
| US-20080181964-A1 | MICROPARTICLES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2008-07-31 | — | — | US | claimed |
| US-7309500-B2 | Microparticles | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2007-12-18 | — | — | US | claimed |
| WO-2005055988-A2 | MICROPARTICLES | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2005-06-23 | — | — | WO | claimed |
| US-20050123614-A1 | Microparticles | BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, THE | 2005-06-09 | — | — | US | claimed |
| EP-3019443-B1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION SENSITIVE FLUORESCENT PROBES | UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | UNIV WASHINGTON (US) | 2026-01-15 | — | — | US | disclosed |
| US-4548893-A | NEGATIVE WORKING, VINYL POLYMER HAVING AROMATIC QUATERNIZED NITROG | GTE LABORATORIES INCORPORATED (US) | 1985-10-22 | — | — | US | disclosed |
| US-4456678-A | High resolution lithographic resist of negative working cationic vinyl polymer | GTE LABORATORIES INCORPORATED (US) | 1984-06-26 | — | — | US | disclosed |
| US-4276362-A | CHARGE TRANSFER COMPLEX | CATALYST RESEARCH CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260014561-A1 | METHODS AND APPARATUS FOR SINGLE BIOLOGICAL NANOPARTICLE ANALYSIS | CD63, SELL, LAMP2 | ACHE 2441/4885HDAC8 3392/4885KDM4E 4271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.